Current Trends and Challenges in Drug-Likeness Prediction: Are They Generalizable and Interpretable?
Health Data Science · 2023-01 · 3
DOI: 10.34133/hds.0098 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Data Science, online erschienen am 10.11.2023. Verfasst von Wenyu Zhu und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, 100191 Beijing, P. R. China. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Importance : Drug-likeness of a compound is an overall assessment of its potential to succeed in clinical trials, and is essential for economizing research expenditures by filtering compounds with unfavorable properties and poor development potential. To this end, a robust drug-likeness prediction method is indispensable. Various approaches, including discriminative rules, statistical models, and machine learning models, have been developed to predict drug-likeness based on physiochemical properties and structural features. Notably, recent advancements in novel deep learning techniques have significantly advanced drug-likeness prediction, especially in classification performance. Highlights : In this review, we addressed the evolving landscape of drug-likeness prediction, with emphasis on methods employing novel deep learning techniques, and highlighted the current challenges in drug-likeness prediction, specifically regarding the aspects of generalization and interpretability. Moreover, we explored potential remedies and outlined promising avenues for future research. Conclusion : Despite the hurdles of generalization and interpretability, novel deep learning techniques have great potential in drug-likeness prediction and are worthy of further research efforts.
Autor:innen und Institutionen
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, 100191 Beijing, P. R. China.
- Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Peking University, 100191 Beijing, P. R. China.
ORCID-Profile: Zhenming Liu
Zitieren
APA
Zhu, W., Wang, Y., Niu, Y., Zhang, L., & Liu, Z. (2023). Current Trends and Challenges in Drug-Likeness Prediction: Are They Generalizable and Interpretable?. Health Data Science, 3. https://doi.org/10.34133/hds.0098
Vancouver
Zhu W, Wang Y, Niu Y, Zhang L, Liu Z. Current Trends and Challenges in Drug-Likeness Prediction: Are They Generalizable and Interpretable?. Health Data Science. 2023;3. doi:10.34133/hds.0098
BibTeX
@article{Zhu2023,
author = {Zhu, Wenyu and Wang, Yanxing and Niu, Yan and Zhang, Liangren and Liu, Zhenming},
title = {Current Trends and Challenges in Drug-Likeness Prediction: Are They Generalizable and Interpretable?},
journal = {Health Data Science},
year = {2023},
volume = {3},
doi = {10.34133/hds.0098}
}
EUVIMED